NCT00578981

Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

Wiser Choices in Osteoporosis Trial: The OSTEOPOROSIS CHOICE Decision Aid to Support the Decision to Use or Not Use Bisphosphonates in Postmenopausal Women at Risk of Osteoporotic Fractures.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: Female
• Age: 50 Years – 90 Years
• Healthy volunteers: Accepted

Summary

To develop a decision aid to support the decision to use (or not use) bisphosphonates in postmenopausal women at risk for osteoporotic fractures, and to assess the impact of the decision aid on start and six month adherence to bisphosphonates.

Detailed description

Bisphosphonates can reduce fracture risk in patients with osteoporosis. However, many patients may not start and adhere to bisphosphonates, consequently losing independence, quality, and length of life. We hypothesize that a decision aid that efficiently improves patient education and communication with their provider about fracture risk, and about using bisphosphonates to reduce that risk, will improve the quality of treatment decisions. We anticipate that patients will become more involved in the decision-making process and decisions will be more consistent with patients' values and health care goals. We expect this will lead to increased bisphosphonate start and adherence and improved patient outcomes.

Conditions

• Osteoporosis
• Bone Loss, Age Related
• Postmenopausal Bone Loss
• Postmenopausal Osteoporosis

Interventions

Type	Name	Description
BEHAVIORAL	Osteoporosis Choice Decision Aid	The provider will introduce the patient to the choice of bisphosphonates using the decision aid.

Timeline

• Start date: 2007-08-01
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2007-12-21
• Last updated: 2016-02-02

Locations

1 site across 1 country: United States